Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420237 · ClinicalTrials.gov registry record · NA
Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 367
- Enrollment target
NCT01420237: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT01420237 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 367 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01420237, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 367 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.
Primary Outcome
Defined as absence of postoperative femoral head dislocation.
Interventions
- DEVICE Restoration ADM X3 Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2011-06 |
| Est. Completion | 2023-11-09 |
| Phase | NA |
Why NCT01420237 stopped before completion
NCT01420237 is an interventional study that assigns participants to a tested intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Restoration ADM X3 Device is the first listed.
NCT01420237 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01420237 about?
NCT01420237 is a clinical study titled "Restoration® Anatomic Dual Mobility (ADM) X3® Acetabular System Study". The purpose of this study is to evaluate the success rate of cementless primary hip replacement with the Restoration® ADM X3® Acetabular System as compared to other primary hip systems in the literature, through absence of femoral head dislocation at 10 years postoperative.
What is the current status of trial NCT01420237?
This trial is currently terminated. It is a NA study. The enrollment target is 367 participants. The study started on 2011-06. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT01420237?
The interventions under investigation include: Restoration ADM X3 Device (DEVICE).
Who is sponsoring clinical trial NCT01420237?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01420237's enrollment target sits among peer trials
367 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia